Disease and Therapy Review: Ovarian Cancer

Disease and Therapy Review: Ovarian Cancer

The Ovarian Cancer Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, with additional information provided for the distribution of ovarian cancer by stage. Information on symptoms and diagnosis is provided, with discussion of risk factors and tests used to detect and diagnose ovarian cancer. Treatment options by stage and type (stage I and II epithelial; stage III and IV epithelial; recurrent or persistent epithelial; prevention; and ovarian germ cell cancer) are discussed. Dosing and treatment costs for chemotherapy agents are provided, along with market size estimates and annual sales of leading therapies. 
 



Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format.  These reports are prepared by the senior market research team of Timely Data Resources.  Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities.  Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends.  The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment.  This information is supplemented by reviews of analyst reports, company reports, and medical websites.  Sources and references are provided. 

I. OVERVIEW

General description of the condition

Types of ovarian cancer

II. INCIDENCE, PREVALENCE AND MORTALITY

Incidence Table (US, Canada, UK, France, Germany, Italy, Spain, Japan, China, India, Mexico, Worldwide)

Prevalence Table (US, Canada, UK, France, Germany, Italy, Spain, Japan, China, India, Mexico, Worldwide)

Mortality Table (US, Canada, UK, France, Germany, Italy, Spain, Japan, China, India, Mexico, Worldwide)

III. SYMPTOMS AND DIAGNOSIS

Symptoms

Risk factors

Diagnostic tests

Staging of epithelial cancer

IV. TREATMENT

By stage for epithelial cancer

Prevention

Treatment for other forms of ovarian cancer

V. DOSING AND TREATMENT COSTS

VI. MARKET SIZE

VII. COMMENTS

VIII. REFERENCES/RESOURCES